Tag

PrEP

Volunteers Needed For New PrEP Study That Could Revolutionize HIV Prevention

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
Increased public awareness and use of pre-exposure prophylaxis (PrEP) has been tremendously powerful in the global battle against HIV/AIDS. Studies have shown that, when taken as a daily pill, PrEP is 92-99% effective at preventing HIV infections in HIV-negative individuals. However, as with any daily medication, strict adherence is the key to success – and, for many people, this may become a barrier to PrEP’s effectiveness. The Fenway Institute is serving as a site for a new study, HPTN 083, that explores whether injectable, long-acting PrEP, is a viable alternative to oral PrEP. Injectable PrEP has the potential to truly 
Read More

Help Shape The Future Of HIV Prevention: Join A Research Study Today

By | HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
The battle against HIV/AIDS has shifted dramatically in the past decade, as our understanding of the virus and how to combat it has increased. The introduction of Pre-Exposure Prophylaxis (PrEP), a daily pill commonly known as Truvada, has been an incredible game changer for HIV prevention. Currently, condom use and PrEP are the most proven effective methods for protection against HIV infection. “Using Truvada for PrEP has been revolutionary for HIV prevention, but, unfortunately, it’s not a one size fits all solution,” said Ryan Tappin, Clinical Manager, Biomedical Research at The Fenway Institute. “The more choices for PrEP that patients 
Read More

Massachusetts PrEP Drug Assistance Program Now Open Statewide

By | Fenway Health Newsroom, HIV/AIDS | No Comments
Pre-Exposure Prophylaxis, or PrEP, is a proven tool for drastically reducing an individual’s risk of HIV infection. Unfortunately, this daily pill – also commonly known as Truvada – can be cost prohibitive, especially for those without health insurance. To make this life-saving drug available to all who need it, a statewide Drug Assistance Program (DAP) is now available across Massachusetts to income-eligible residents. Piloted by the Office of HIV/AIDS (OHA), the PrEP DAP covers the costs of medication co-pays and deductibles for clients who have insurance and provides financial assistance for accessing PrEP to uninsured individuals, including insurance enrollment assistance. 
Read More

Edge Media Names Policy Brief On PrEP For Transgender Women As One Of Top Women’s Health Stories Of 2016

By | Fenway Health Newsroom, HIV/AIDS, Trans | No Comments
Edge Media Network has highlighted policy brief “Transgender women and pre-exposure prophylaxis for HIV prevention: What we know and what we still need to know” as one of the most important women’s health stories of 2016. The brief was released last winter by the National Center for Innovation in HIV Care—a program of The Fenway Institute, AIDS United, and ARCW. In it, researchers explored the interaction between feminizing hormones used by transgender women, and the medication currently approved for use as pre-exposure prophylaxis for HIV prevention (PrEP). The brief also brought attention to the urgent need for more lifesaving research 
Read More

Ready for Vacation? New Study Puts the “PrEP” in “Travel Preparation”

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
It’s officially vacation season, and many people are off to seaside getaways and exciting new destinations. A vacation from work, however, shouldn’t mean a vacation from making smart decisions about your sexual health. According to a 2013 study of men who have sex with men (MSM), 25.6 % reported condomless anal sex with new male sex partners while vacationing, and 1 in 5 reported going on vacation with a main goal of finding new sexual partners. From Provincetown to Fire Island, from gay cruises to circuit parties, LGBT safe spaces have always been spaces for freedom and sexual expression. Taking 
Read More